Assessment of the mouse as an experimental model for studying polymorphic oxidation of the sparteine/debrisoquine type

This publication has 8 references indexed in Scilit:

• The genetic polymorphism of debrisoquine/sparteine metabolism — Clinical aspects
  Pharmacology & Therapeutics, 1990
• The specificity of inhibition of debrisoquine 4-hydroxylase activity by quinidine and quinine in the rat is the inverse of that in man
  Biochemical Pharmacology, 1989
• Antipyrine metabolism in female Lewis and Dark Agouti strains of rats, which are extensive and poor metabolizers of debrisoquine, respectively.
  The Japanese Journal of Pharmacology, 1989
• Debrisoquine 4-Hydroxylase: Characterization of a New P450 Gene Subfamily, Regulation, Chromosomal Mapping, and Molecular Analysis of the DA Rat Polymorphism
  DNA, 1987
• Bufuralol 1'-hydroxylase activity of the rat
  Biochemical Pharmacology, 1986
• Metoprolol metabolism and debrisoquine oxidation polymorphism‐ population and family studies.
  British Journal of Clinical Pharmacology, 1985
• Thiopurine methyltransferase: mouse kidney and liver assay conditions, biochemical properties and strain variation
  Biochemical Pharmacology, 1985
• Animal modelling of human polymorphic drug oxidation—the metabolism of debrisoquine and phenacetin in rat inbred strains
  Journal of Pharmacy and Pharmacology, 1981